Michael Leonard Buys Shares of Ingredion Incorporated
Michael Leonard, a senior executive at Ingredion, recently bought 34 shares, highlighting insider confidence.
Key Points
- Michael Leonard, SVP at Ingredion, purchased 34 shares at $101.51 each on June 15, 2026.
- Ingredion's market cap is $6.4 billion, with a P/E ratio of 9.77 and a 52-week range of $97.12 to $140.47.
- Analysts maintain a 'hold' consensus with a mean price target of $122.83, reflecting mixed sentiment.
Michael Leonard, the Senior Vice President, Chief Information Officer, and Head of Protein Fortification at Ingredion Incorporated, purchased 34 shares of the company on June 15, 2026. He bought these shares at an average price of $101.51 each, totaling approximately $3,451.34. This transaction was not part of a pre-planned trading program.
Insider Buying and Selling at Ingredion Incorporated
In addition to Michael Leonard, David Eric Seip, another Senior Vice President at Ingredion, also bought shares recently. On June 15, 2026, Seip purchased 17 shares at $101.50 each. Earlier, on May 29, both Leonard and Seip acquired shares at $101.44 each. These transactions indicate a pattern of insider buying, suggesting confidence in the company's prospects.
Other Institutional Activity in Ingredion
Several large institutional investors have also adjusted their positions in Ingredion. BlackRock, Inc. increased its holdings by 228,122 shares, reaching a total of 6,350,063 shares valued at about $715.4 million. Dimensional Fund Advisors LP added 175,600 shares, bringing its total to 3,115,136 shares worth around $350.9 million. Meanwhile, First Trust Advisors LP significantly boosted its stake by 1,059,324 shares, ending with 3,054,149 shares valued at $344.1 million. AQR Capital Management LLC also increased its holdings by 379,956 shares, totaling 2,205,974 shares worth approximately $247.5 million.
Ingredion Incorporated Stock Snapshot
Shares of Ingredion Incorporated (NYSE: INGR) recently traded at $101.51. The company has a market capitalization of approximately $6.4 billion and a P/E ratio of 9.77, indicating relatively low valuation compared to earnings. Ingredion's stock has seen a 52-week low of $97.12 and a high of $140.47. The stock's 50-day moving average is $107.07, while the 200-day moving average stands at $113.37. Ingredion maintains a strong financial position with a current ratio of 2.76 and a quick ratio of 1.78, alongside a debt-to-equity ratio of 41.43.
Recent Earnings
Ingredion reported revenue of $7.2 billion, though it experienced a slight revenue decline of 1.2%. The company's earnings per share (EPS) stand at $10.39, with a net margin of 9.36% and a return on equity (ROE) of 16.19%. Ingredion is set to announce its next earnings on August 4, 2026.
Analysts Set New Price Targets
Recent analyst activity includes Barclays maintaining a 'hold' rating with a price target of $120 on May 6, 2026. Oppenheimer kept a 'buy' rating, setting their target at $126 on April 22, 2026. UBS maintained a 'hold' rating with a $122 target on April 9, 2026. The consensus among analysts is a 'hold' rating, with a mean price target of $122.83 based on six analyst opinions.
About Ingredion Incorporated
Ingredion Incorporated is a leading global provider of ingredient solutions, primarily derived from corn and other starch-based materials. Headquartered in Westchester, Illinois, the company operates across several segments, including Texture & Healthful Solutions and Food & Industrial Ingredients in both LATAM and U.S./Canada regions. Ingredion's product offerings include sweeteners, starches, nutrition ingredients, and biomaterials used in various industries such as food and beverage, paper, textiles, and pharmaceuticals. Led by CEO James P. Zallie, Ingredion employs approximately 11,000 people worldwide.
Bottom Line
Michael Leonard's recent purchase of Ingredion shares suggests insider confidence in the company's future. Ingredion's solid financial metrics and ongoing institutional interest highlight its stability. However, with analysts maintaining a 'hold' consensus, investors may view Ingredion as a stable, yet cautious, investment opportunity. As always, it's important to remember that insider transactions and institutional filings are backward-looking and may not reflect current positions.
See Also
This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.
